Key result
Quercetin fails to impact blood pressure or amplify tamsulosin hemodynamics in hypertensive rats.
Why the study?
To examine if the supplement-drug interaction between quercetin and tamsulosin luxates hypotensive and orthostatic events in vivo in rats.
Does quercetin alter the haemodynamic effects of tamsulosin or reduce blood pressure in hypertensive and normotensive rats?
Does quercetin alter the haemodynamic effects of tamsulosin or reduce blood pressure in hypertensive and normotensive rats?
Quercetin does not amplify the haemodynamic effects of tamsulosin or orthostatic challenges, nor does it lower blood pressure in spontaneously hypertensive rats.
Quercetin shows no tamsulosin interaction or BP lowering in SHR; leaves open any human antihypertensive role.
BACKGROUND AND To examine if this supplement-drug interaction luxates hypotensive and orthostatic events in vivo, several set of studies were conducted in spontaneously hypertensive (SHR) and normotensive (Wistar Kyoto [WKY]) rats. EXPERIMENTAL APPROACH: First, in rats pretreated with quercetin or its vehicle, responses to phenylephrine and tamsulosin were examined. Second, tamsulosin-induced changes in renal, mesenteric, hindquarter and carotid conductance were compared in quercetin- and vehicle-treated rats instrumented with Doppler flow probes. Animals were also placed on a tilt table to record regional haemodynamic changes to orthostatic challenges. Third, adult SHR were instrumented with telemeters to measure 24-hr patterns of BP. Recordings were made before and during a 5-week oral treatment of quercetin. Finally, pre-hypertensive SHR were treated with quercetin from 4 to 8 weeks of age and arterial pressure was measured at 8 and 12 weeks. KEY RESULTS: Pretreatment with quercetin did not influence the responses to phenylephrine and tamsulosin, in neither WKY nor SHR. While tamsulosin treatment and tilting lowered BP and increased conductance in all vascular beds, effect size was not influenced by pretreatment with quercetin. Prolonged treatment with quercetin, in either prehypertensive SHR or adult SHR with established hypertension did not lower BP. CONCLUSIONS AND IMPLICATIONS: Cumulatively, these data demonstrate that quercetin does not amplify haemodynamic effects of tamsulosin or tilting in vivo in rats and has no effect on BP development in SHR.
No takes yet. Share an insight, caveat, or question.
Vrolijk et al. (2019) studied Hypertension. Quercetin vs. Vehicle was evaluated on Haemodynamic responses to phenylephrine and tamsulosin, and blood pressure. Quercetin did not amplify the haemodynamic effects of tamsulosin or tilting in vivo in rats and had no effect on blood pressure development in spontaneously hypertensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: